Stage III Ovarian Cancer AJCC v6 and v7 Active Not Recruiting Phase 1 Trials for Irinotecan (DB00762)

Indication	Status	Phase
DBCOND0093245 (Stage III Ovarian Cancer AJCC v6 and v7)	Active Not Recruiting	1

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00576654	Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by Surgery	Treatment	Camptothecin (DB04690) Irinotecan (DB00762) Veliparib (DB07232)